Atlas Venture Fund X, L.P. 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-06 5:00 pm Sale | 2022-11-23 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X, L.P. | 1,498,635 3.000% | -665,402 (-30.75%) | Filing |
| 2022-09-14 5:06 pm Sale | 2022-09-12 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X, L.P. | 2,164,037 4.400% | -360,829 (-14.29%) | Filing |